Manhattan Scientifics eyes large acquisition as it continues to incubate transformative technologies

Manhattan Scientifics founder and chairman Marvin Maslow takes Proactive through his own background and the business model and strategy of the company, which is focused on technology transfer and commercialization of transformative technologies.

Maslow explained that Manhattan Scientifics has assisted in incubating and financing four IPO’s working closely with Science Teams at the Los Alamos National Laboratory and the Sandia National Laboratory in New Mexico.

Next up, the company is planning the acquisition of a substantial technology company as a prelude to an uplist to a major exchange, such as Nasdaq.

© 2022 Stockmark.it The Latest StockMarket News and Interviews